Literature DB >> 8977184

Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response.

C Pardoux1, C Asselin-Paturel, J Chehimi, F Gay, F Mami-Chouaib, S Chouaib.   

Abstract

IL-12 is an important cytokine in the control of cell-mediated immunity. We have investigated the functional interaction of IL-12 with TGF-beta1, a cytokine involved in the regulation of growth and differentiation of immunocompetent cells, during human allogeneic response development. Using primary MLR, our data show that addition of exogenous TGF-beta at the sensitizing phase of the primary MLR resulted in the inhibition of both allogeneic cytotoxic and proliferative responses. The inhibitory effect of TGF-beta on allogeneic response involves an abrogation of IL-12/p70 production upon allostimulation. In contrast to its effect on IL-12 production, TGF-beta did not alter the expression of IL-12R beta1-chain (IL-12R beta) in T cells induced upon allogeneic activation. Addition of exogenous IL-12 or IFN-gamma in the MLR cultures in the presence of TGF-beta did not result in reversal of CTL generation and T cell proliferation. Interestingly, TGF-beta was efficient in down-regulating IL-12 responsiveness of alloactivated T cells as well as TCR-alphabeta or TCR-gammadelta alloreactive T cell clones. These studies suggest that the inhibitory effect of TGF-beta on the development of human allogeneic proliferation and cytotoxic responses involves an additional mechanism associated with an interference with IL-12 pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8977184

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Reduced interleukin-12, interleukin-18, and interferon-gamma production with prolonged rat hepatic allograft survival after donor-specific blood transfusion.

Authors:  Y Yamaguchi; F Matsumura; J Liang; E Akizuki; T Matsuda; K Okabe; H Ohshiro; K Ishihara; S Yamada; K Mori; M Ogawa
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

3.  Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.

Authors:  Oliver Grauer; Peter Pöschl; Annette Lohmeier; Gosse J Adema; Ulrich Bogdahn
Journal:  J Neurooncol       Date:  2006-11-15       Impact factor: 4.130

4.  Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression.

Authors:  S L Giannini; W Al-Saleh; H Piron; N Jacobs; J Doyen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

5.  Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis.

Authors:  M Ohana; K Okazaki; C Oshima; K Kawasaki; T Fukui; H Tamaki; M Matsuura; M Asada; T Nishi; K Uchida; S Uose; H Nakase; M Iwano; Y Matsushima; H Hiai; T Chiba
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

6.  Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell.

Authors:  Hiroyasu Ito; Mitsuru Seishima
Journal:  J Biomed Biotechnol       Date:  2010-05-19

7.  Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

Authors:  L Z Chen; G M Hochwald; C Huang; G Dakin; H Tao; C Cheng; W J Simmons; G Dranoff; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort.

Authors:  Diana N J Lockwood; Lavanya Suneetha; Karuna Devi Sagili; Meher Vani Chaduvula; Ismail Mohammed; Wim van Brakel; W C Smith; Peter Nicholls; Sujai Suneetha
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.